Partnering opportunity

Enzymatic/microbial platform technology offers solutions for biocatalysis for chemical, food, pharma and materials industry

Summary

German-Sino SME provides all-in-one R&D /commercialisation services and biocatalytic solutions via an enzymatic, microbial platform technology. It leads to major time savings, state of the art high throughput screening with 500,000 CPU (central processing unit) hours/year, high accuracy and consistency. They look for industrial/academic partners from chemical, pharma, food, home care, material industry for R&D cooperation, e.g. new synthetic routes to speciality/fine/pharmaceutical chemicals

Partner sought

They look for industrial/academic partners from the fields pharma, food and feed, chemistry, personal and home care as well as from materials for research and development cooperations. Therein the company provides enzyme technology solutions in the partner’s R&D projects regarding, for example, new synthetic routes towards specialty, fine and pharmaceutical chemicals. However, optimization of the partner’s existing processes, by the optimization and/or implementation of enzymes is also possible They are also open to other forms of cooperation.

Description

Traditional ways to produce pharmaceuticals and other chemicals often require environmentally unfriendly reagents and harsh conditions, such as heavy metals, corrosive acids and high temperatures. Enzymes, functioning as proteins with green and excellent catalytic performance, offer efficient, eco-friendly and safe alternatives for traditional chemistry and can even significantly shorten synthetic routes. However, the industrial applicability of natural enzymes as biocatalysts is often restricted by, for example, their limited activity on unnatural substrates and instability at industrial process conditions, such as the necessity of organic co-solvents and high substrate loadings. A German-Sino company provides solutions which overcome the limitations of natural enzymes in industrial biocatalysis. The company provides an all-in-one R&D and commercialization service package spanning from first assessment of customer's needs to final industrial realization of developments. This whole process is guided by a team of highly experienced scientists from all over the world applying the latest state of the art technologies. With their extensive experience in directed enzyme evolution, strain engineering, fermentation process development and commercial-scale biocatalytic production, they successfully apply a proprietary R&D platform to develop novel, optimized enzyme technologies. This enzyme directed evolution platform is spearheaded by the integration of bioinformatic database guided design, computer modelling and simulations, as well as state of the art high throughput screening systems. Fields of application are fine chemical, pharmaceutical, food, personal and home care and material industries. They are also exploring the development of biocatalysis technology for feed, environmental and waste treatment industries. They look for industrial / academic partners from the fields mentioned above to offer enzyme technology solutions in the partner’s R&D projects regarding, for example, new synthetic routes towards specialty, fine and pharmaceutical chemicals. They also enable the optimization of the partner’s existing processes, by the optimization and/or implementation of enzymes. The company is also open to other forms of cooperation.

Advantages and innovations

The proprietary enzyme engineering platform of the German-sino SME is a combination of two Nobel prize winning technologies (directed evolution and computational enzyme engineering), with the following key advantages: - The application of bioinformatics-assisted design, simulations and analysis of protein mutations leads to major time savings and higher success rates within in the development of novel industrial enzymes. - State of the art high throughput screening technologies and a supercomputer account with 500,000 CPU (central processing unit) hours/year allow for time efficient and parallel handling of up to six computer aided enzyme evolution projects. - Automated and controlled laboratory procedures deliver higher accuracy and consistency of experimental results. - The created novel enzymes provide unpreceded performance in nature, meet industrial applicability criteria and generate new intellectual property. - The developed enzymatic processes have been proven to enable the manufacturing of diverse optically pure value-added products.

Development stage

Already on the market

Intellectual Property Rights (IPR)

Secret Know-how,Patent(s) applied for but not yet granted


Register your interest

How it works

  • Tell us about yourself
  • We’ll discuss with you
  • We put the right partners in touch

EEN help you find the right partner, rather than you going it alone.

Our role is to review and collate the most suitable submissions, and then send them to the client who posted the opportunity. We consult with you, and the client, to make the process professional and easy.

These are live opportunities. Your registration of interest on the site is just like a professional approach to a business at a networking event. To stand the best chance of success, make your submission really sing. Sell why the client who posted the opportunity should work with you. Excite them. Ask questions. Try and avoid copy and pasting words from elsewhere.

Once the client has chosen their partner, we'll introduce them over email and keep in touch with both parties to see how it's going. Sometimes things progress quickly. Sometimes because of changing priorities for either party, things progress slowly, but you never know - your next big business break could start right here.

?What value does EEN add?
This is your pitch: remember to include your unique selling points (USP) and why someone would want to do business with you
Tell us why you are a good fit for this opportunity, and why you think you're the right people for this partnership
If there's anything additional, or commercially sensitive you'd like to know about this opportunity, please let us know

When you entered your email address above, we emailed you a code to verify you're human and have access to that account.

?What's this?

What next?

To finish up, we just need some extra details about you and your company